The business covers 34 or more regions
The business network covers major cities across the country and connects Shandong with other regions
2015Year
34+
1000+
5+Jinan Jun Dao Xin Medical Devices Co., Ltd.
Founded in 2015, Jundaoxin is driven by a global perspective and a deep understanding of local medical needs. We are dedicated to pioneering technological iterations and industrial upgrades. By fostering a robust "Industry-Academia-Research-Hospital" synergy, we collaborate with top-tier universities and Class-A hospitals to transform cutting-edge research into a powerful force that safeguards life.
Over the years, we have lived our commitment: "Empowering Healthcare with Technology, Safeguarding Health with Quality." We equip clinicians with superior tools and provide patients with compassionate care. Looking ahead, Jundaoxin will continue to deliver high-value medical solutions, driving the steady progress of China’s healthcare industry.
Development Milestone
2015
The company was officially established with a focus on the medical device field and the formation of a core R&D team.
2016
Launched the development of core medical device technologies and established foundational laboratory facilities.
2017
Completed the first-generation product prototype and conducted internal functionality and safety testing.
2018
Continuously optimized product performance, stability, and clinical applicability, refining the overall technical roadmap.
2019
Carried out multiple clinical studies and application validations to support future product registration and compliance.
2020
Introduced a medical device quality management system to standardize R&D processes and strengthen compliance and quality control.
2021
Finalized core product design and initiated preparations for medical device regulatory submissions.
2022
Advanced product registration, testing, and certification processes, laying the regulatory foundation for commercialization.
2023
Completed production planning and market research, and began building sales and service capabilities.
2024
The company officially transitioned into an integrated medical device enterprise covering R&D, manufacturing, and sales, with the first product launched to market.
2025
Expanded market presence across medical institutions and continued to strengthen distribution channels and brand recognition.